Abstract
Abstract The pharmacological concept that inhibition of the drug efflux pump P-glycoprotein (P-gp) enhances brain distribution of the antidepressant imipramine in the rat has recently been demonstrated. To determine if these findings are relevant to humans, the present study investigated if imipramine is a transported substrate of human P-gp. Furthermore, additional experiments were carried out to determine if findings in relation to imipramine and human P-gp would apply to other antidepressants from a range of different classes. To this end, bidirectional transport experiments were carried out in the ABCB1-transfected MDCKII-MDR1 cell line. Transported substrates of human P-gp are subjected to net efflux in this system, exhibiting a transport ratio (TR) â
| Original language | English |
|---|---|
| Pages (from-to) | 2259-2272 |
| Number of pages | 14 |
| Journal | International Journal of Neuropsychopharmacology |
| Volume | 16 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - Nov 2013 |
Keywords
- Antidepressant
- bidirectional transport study
- imipramine
- MDCKII-MDR1
- P-glycoprotein
Fingerprint
Dive into the research topics of 'Human P-glycoprotein differentially affects antidepressant drug transport: Relevance to blood-brain barrier permeability'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver